Abstract
To explore the effect of radiofrequency ablation (RFA) on survival time and stent patency period in patients with unresectable extrahepatic cholangiocarcinoma (EHCC).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have